Long-Term Outcome of Neoadjuvant Endocrine Therapy with Aromatase Inhibitors in Elderly Women with Hormone Receptor-Positive Breast Cancer

被引：0

作者：

Antonino Grassadonia

Marta Di Nicola

Simona Grossi

Paolo Noccioli

Saveria Tavoletta

Roberto Politi

Domenico Angelucci

Camilla Marinelli

Marinella Zilli

Giampiero Ausili Cefaro

Nicola Tinari

Michele De Tursi

Laura Iezzi

Pasquale Cioffi

Stefano Iacobelli

Clara Natoli

Ettore Cianchetti

机构：

[1] University ‘G. d’Annunzio’,Medical Oncology Unit, Department of Experimental and Clinical Sciences

[2] University ‘G. d’Annunzio’,Laboratory of Biostatistics, Department of Experimental and Clinical Science

[3] ‘G. Bernabeo’ Hospital,Division of Surgical Senology

[4] ‘SS. Annunziata’ Hospital,Division of Pathology

[5] ‘SS. Annunziata’ Hospital,Oncology Department

[6] University ‘G. d’Annunzio’,Radiation Oncology Department

[7] ‘SS. Annunziata’ Hospital,Hospital Pharmacy

[8] University ‘G. d’Annunzio’,Division of Surgical Senology, Department of Experimental and Clinical Sciences

来源：

Annals of Surgical Oncology | 2014年 / 21卷

关键词：

Overall Survival; Trastuzumab; Axillary Lymph Node Dissection; Letrozole; Anastrozole;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1575 / 1582

页数：7

共 50 条

[1] Long-Term Outcome of Neoadjuvant Endocrine Therapy with Aromatase Inhibitors in Elderly Women with Hormone Receptor-Positive Breast Cancer
Grassadonia, Antonino
Di Nicola, Marta
Grossi, Simona
Noccioli, Paolo
Tavoletta, Saveria
Politi, Roberto
Angelucci, Domenico
Marinelli, Camilla
Zilli, Marinella
Cefaro, Giampiero Ausili
Tinari, Nicola
De Tursi, Michele
Iezzi, Laura
Cioffi, Pasquale
Iacobelli, Stefano
Natoli, Clara
Cianchetti, Ettore
[J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (05) : 1575 - 1582
[2] Axillary Management After Neoadjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer
Olga Kantor
Melia Wakeman
Anna Weiss
Stephanie Wong
Alison Laws
Samantha Grossmith
Elizabeth A. Mittendorf
Tari A. King
[J]. Annals of Surgical Oncology, 2021, 28 : 1358 - 1367
[3] Axillary Management After Neoadjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer
Kantor, Olga
Wakeman, Melia
Weiss, Anna
Wong, Stephanie
Laws, Alison
Grossmith, Samantha
Mittendorf, Elizabeth A.
King, Tari A.
[J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (03) : 1358 - 1367
[4] Endocrine Therapy in Premenopausal Hormone Receptor-Positive Breast Cancer
Tevaarwerk, Amye J.
Wisinski, Kari B.
O'Regan, Ruth M.
[J]. JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (11) : 1148 - +
[5] Cyclin-Dependent Kinase 4/6 Inhibitors in Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer
Rossi, Lorenzo
McCartney, Amelia
Risi, Emanuela
De Santo, Irene
Migliaccio, Ilenia
Malorni, Luca
Biganzoli, Laura
Di Leo, Angelo
[J]. CLINICAL BREAST CANCER, 2019, 19 (06) : 392 - 398
[6] Neoadjuvant endocrine therapy for estrogen receptor-positive primary breast cancer
Yamamoto, Yutaka
Goto-Yamaguchi, Lisa
Takeno, Masako
Yamamoto-Ibusuki, Mutsuko
[J]. CHINESE CLINICAL ONCOLOGY, 2020, 9 (03) : 30
[7] Estimating long-term mortality in women with hormone receptor-positive breast cancer: The 'ESTIMATE' tool
Leone, Jose P.
Graham, Noah
Tolaney, Sara M.
Leone, Bernardo A.
Freedman, Rachel A.
Hassett, Michael J.
Leone, Julieta
Vallejo, Carlos T.
Winer, Eric P.
Lin, Nancy U.
Tayob, Nabihah
[J]. EUROPEAN JOURNAL OF CANCER, 2022, 173 : 20 - 29
[8] POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE BREAST CANCER: BALANCING BENEFIT AND TOXICITY FROM AROMATASE INHIBITORS
Ingle, J.
[J]. BREAST, 2013, 22 : S19 - S19
[9] Postmenopausal women with hormone receptor-positive breast cancer: Balancing benefit and toxicity from aromatase inhibitors
Ingle, James N.
[J]. BREAST, 2013, 22 : S180 - S183
[10] Neoadjuvant therapy for hormone receptor-positive breast cancer: challenges and advances
Metzger, O.
[J]. CANCER RESEARCH, 2020, 80 (04)

← 1 2 3 4 5 →